BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 2902609)

  • 1. [Treatment of nocturnal hypoxia in chronic obstructive bronchopneumopathies].
    Weitzenblum E; Kurtz D; Krieger J; Apprill M; Kessler R
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():387-90. PubMed ID: 2902609
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of almitrine, a chemoreceptor stimulator, on nocturnal hypercapnia and pulmonary artery pressure during O2 respiration in chronic obstructive lung disease].
    Rühle KH; Kempf P; Mössinger B; Klein G; Costabel U; Würtemberger G; Matthys H
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():411-4. PubMed ID: 2902613
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nocturnal hypoxemia and hypercapnia in patients with chronic obstructive ventilation disorder. Therapy with almitrine, a peripheral chemoreceptor stimulator].
    Rühle KH; Köhler D; Huber G; Matthys H
    Prax Klin Pneumol; 1985 Jun; 39(6):197-203. PubMed ID: 2862627
    [No Abstract]   [Full Text] [Related]  

  • 4. Is chronic hypoxaemia and/or hypercapnia of the obstructive patient reversible? The role of almitrine bismesylate.
    Eur J Respir Dis Suppl; 1986; 146():609-718. PubMed ID: 2877898
    [No Abstract]   [Full Text] [Related]  

  • 5. Platypnea induced by worsening of VA/Q inhomogeneity in the sitting position in chronic obstructive lung disease.
    Michel O; Sergysels R; Ham H
    Chest; 1988 May; 93(5):1108-10. PubMed ID: 2896103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nocturnal hypoxemia of chronic obstructive bronchopathies and almitrine dimesylate].
    Racineux JL; Hubert P; Meslier N; Monrigal JP
    Rev Med Interne; 1985; 6 Spec No():39-42. PubMed ID: 3834559
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of almitrine dimesylate on pulmonary hemodynamics in healthy subjects and in patients with chronic obstructive bronchitis].
    Ansquer JC
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():409-10. PubMed ID: 2902612
    [No Abstract]   [Full Text] [Related]  

  • 8. Improvement in ventilation-perfusion matching by almitrine in COPD.
    Mélot C; Naeije R; Rothschild T; Mertens P; Mols P; Hallemans R
    Chest; 1983 Mar; 83(3):528-33. PubMed ID: 6130897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of almitrine dimesylate on gas exchange. Preliminary results in patients with chronic obstructive bronchopneumopathies under artificial ventilation].
    Castaing Y; Manier G; Guenard H
    Presse Med; 1984 Oct; 13(34):2078-82. PubMed ID: 6149535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of arterial hypoxia in chronic obstructive pulmonary disease.
    Keighley FJ; Mithoefer JC
    Chest; 1972 Aug; 62(2):Suppl:45S-49S. PubMed ID: 5049521
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lung function and blood gas analysis studies in patients with COPD and respiratory insufficiency receiving almitrine medication with special reference to its clinical aspects].
    Hillebrand M; Siemon G
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():391-3. PubMed ID: 2902610
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic bronchopneumopathies. A new therapeutic approach].
    Chrétien J
    Presse Med; 1984 Oct; 13(34):2043-4. PubMed ID: 6149529
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of almitrine and oxygen on ventilation and gas exchange in patients with chronic respiratory insufficiency.
    Hawryłkiewicz I; Jedrzejewska-Makowska M; Górecka D; Zieliński J
    Eur J Respir Dis; 1983 Oct; 64(7):512-6. PubMed ID: 6138276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sleep and nocturnal desaturation of patients with chronic obstructive bronchopneumopathies. Effects of almitrine bismesylate administered orally].
    Kurtz D; Weitzenblum E; Krieger J; Reitzer B; Roujansky P
    Rev Mal Respir; 1985; 2 Suppl 1():S45-52. PubMed ID: 2870547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of chronic hypoxemia in COPD].
    Weitzenblum E
    Rev Mal Respir; 1993; 10(2):139-45. PubMed ID: 8502795
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of oral almitrine on the distribution of VA/Q ratio in chronic obstructive lung diseases (author's transl)].
    Castaing Y; Manier G; Varène N; Guénard H
    Bull Eur Physiopathol Respir; 1981; 17(6):917-32. PubMed ID: 7032629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional ventilation-perfusion and hypoxia in cryptogenic fibrosing alveolitis.
    McCarthy D; Cherniack RM
    Am Rev Respir Dis; 1973 Feb; 107(2):200-8. PubMed ID: 4683577
    [No Abstract]   [Full Text] [Related]  

  • 18. Almitrine as a long term treatment for chronic obstructive pulmonary disease.
    Kauffmann F
    Bull Eur Physiopathol Respir; 1987; 23(6):667. PubMed ID: 2899444
    [No Abstract]   [Full Text] [Related]  

  • 19. [Peripheral neuropathy in chronic bronchopathy. A study of 128 patients].
    Lerebours G; Nouvet G; Senant J; Moore N; Arnaud F
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():400-2. PubMed ID: 2902611
    [No Abstract]   [Full Text] [Related]  

  • 20. Adult domiciliary oxygen therapy. The Thoracic Society of Australia and New Zealand.
    Breslin AB; Colebatch HJ; Engel LA; Young IH
    Med J Aust; 1991 Apr; 154(7):474-7. PubMed ID: 2005846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.